Skip to main content

Table 1 The age-specific prevalence of HPV infections in early-stage CSCC patients

From: Prevalent distribution and survival outcome of HPV infection in patients with early-stage cervical cancer in Hangzhou, China

Age (at surgery)

N

HPV (−), (%)

HPV (+), (%) (LR or HR)

HR-HPV (+), %

LR-HPV ( +)

Single

Multiple

Subtotal

%

< 26

4

1 (25.0)

3 (75.0)

3 (75.0)

0

3 (75.0)

0

26–35

123

15 (12.2)

108 (87.8)

88 (71.5)

20 (16.3)

108 (87.8)

5 (4.1)

36–45

461

62 (13.4)

399 (86.6)

336 (72.9)

57 (12.4)

393 (85.3)

23 (5.0)

46–55

517

104 (20.1)

413 (79.9)

342 (66.2)

61 (11.8)

403 (78.0)

28 (5.4)

> 55

320

42 (13.1)

278 (86.9)

229 (71.6)

42 (13.1)

271 (84.7)

26 (8.1)

Total cases

1425

224 (15.7)

1201 (84.3)

998 (70.0)

180 (12.6)

1178 (82.6)

82 (5.8)

  1. HR-HPV high risk human papillomavirus, LR-HPV low risk human papillomavirus